Examkin

Soru

Zorluk: KolaySubstance-Related and Addictive Disorders

A 28-year-old woman presents to the outpatient clinic seeking treatment for heroin addiction. She states that her last heroin use was approximately 18 hours ago. She currently complains of severe muscle aches, abdominal cramps, and anxiety. On physical examination, she exhibits rhinorrhea, piloerection, and pupillary dilation. The physician plans to initiate treatment with buprenorphine-naloxone. Arrange the following steps in the most appropriate sequential order for the comprehensive management of this patient's opioid use disorder, from immediate acute presentation to long-term care.

  1. 1Assess the severity of withdrawal using a validated clinical scale (e.g., Clinical Opiate Withdrawal Scale).
  2. 2Administer the initial induction dose of sublingual buprenorphine-naloxone.
  3. 3Titrate the buprenorphine-naloxone to an effective daily maintenance dose to suppress cravings.
  4. 4Integrate long-term behavioral counseling and psychosocial support.

Cevap

The correct sequence is: Assessment of withdrawal severity, followed by Induction with buprenorphine-naloxone, followed by Titration to an effective maintenance dose, and finally Integration of long-term psychosocial support.
The appropriate management of opioid use disorder begins with an objective assessment of withdrawal severity (e.g., using the Clinical Opiate Withdrawal Scale). Because buprenorphine is a partial mu-opioid agonist with high affinity, administering it too early can precipitate severe withdrawal. Once moderate withdrawal is confirmed, induction with buprenorphine-naloxone is performed. Over the next few days, the dose is titrated to a steady maintenance level that suppresses cravings. Finally, for the highest chance of sustained remission, pharmacological maintenance is combined with long-term behavioral counseling.

Adım Adım Çözüm

1
Quantify the severity of acute opioid withdrawal.
Objective confirmation that the patient is in moderate to severe withdrawal.
Buprenorphine is a partial mu-opioid agonist. Administering it while full agonists are still occupying receptors can precipitate severe withdrawal.
2
Induce with buprenorphine-naloxone.
Relief of acute withdrawal symptoms.
Once appropriate withdrawal severity is confirmed, the initial dose safely displaces any remaining full agonists and begins treating the withdrawal syndrome.
3
Titrate the medication to a maintenance dose.
Achieve a stable maintenance dose that prevents relapse.
The dose must be carefully adjusted over subsequent days to ensure cravings are completely suppressed.
4
Provide long-term psychosocial support.
Long-term relapse prevention and behavioral modification.
Pharmacotherapy combined with behavioral counseling yields the highest rates of sustained recovery in opioid use disorder.

Anahtar Kavram

The clinical sequence for Opioid Use Disorder management using buprenorphine requires assessing for moderate withdrawal prior to induction to avoid precipitated withdrawal, followed by dose stabilization and long-term counseling.
Bu soruyu puanla

Konular

Substance-Related and Addictive Disorders

Bu konudan daha fazla soru